Zymeworks (ZYME) EBITDA Margin (2021 - 2026)
Zymeworks (ZYME) recorded EBITDA Margin of -894.27% in Q2 2026, down 898.00 percentage points from 3.73% a year earlier but up 1015.16 percentage points from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) EBITDA Margin (2021 - 2026) Analysis & Trends
On a TTM basis, Zymeworks' EBITDA Margin came in at -405.77% as of Jun 30, 2026, down 346.68 percentage points year-over-year; for FY2025, it came in at -80.05%, up 88.26 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +381.95 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -168.31% in FY2024 (-0.06 pp), -168.25% in FY2023 (-201.65 pp), 33.40% in FY2022 (+817.14 pp) and -783.74% in FY2021 (-321.74 pp).
- Quarterly EBITDA Margin has ranged from -3664.93% in Q1 2022 to 79.77% in Q4 2022 over the past five years.
- On a year-over-year basis, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of -463.79 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 3594.61 percentage points in Q1 2023, against a drop of 1824.53 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -1909.43% (Q1 2026), -1712.49% (Q4 2025) and -74.44% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Zymeworks | 2.24 Bn | 1.27 Bn | - | 69.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 69.98% |
| Jun 30, 2026 | -892.37% |
| Mar 31, 2026 | -1,908.35% |
| Dec 31, 2025 | -1,712.49% |
| Sep 30, 2025 | -74.44% |
| Jun 30, 2025 | 3.73% |
| Mar 31, 2025 | -84.89% |
| Dec 31, 2024 | -61.93% |
| Sep 30, 2024 | -201.19% |
| Jun 30, 2024 | -212.96% |
| Mar 31, 2024 | -359.31% |
| Dec 31, 2023 | -125.32% |
| Sep 30, 2023 | -182.75% |
| Jun 30, 2023 | -735.43% |
| Mar 31, 2023 | -70.32% |
| Dec 31, 2022 | 79.77% |
| Sep 30, 2022 | -1,855.07% |
| Jun 30, 2022 | -1,181.29% |
| Mar 31, 2022 | -3,664.93% |
| Dec 31, 2021 | -200.57% |
API Access
Zymeworks EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();